Teriflunomide and Appendicitis - a phase IV clinical study of FDA data

Summary:

Appendicitis is reported as a side effect among people who take Teriflunomide (teriflunomide), especially for people who are female, 30-39 old, also take Vitamin D, and have Multiple sclerosis relapse.

The phase IV clinical study analyzes which people have Appendicitis when taking Teriflunomide. It is created by eHealthMe based on reports of 5,064 people who have side effects when taking Teriflunomide from the FDA, and is updated regularly.

What is Teriflunomide?

Teriflunomide has active ingredients of teriflunomide. eHealthMe is studying from 5,067 Teriflunomide users. Check the latest studies of Teriflunomide.

What is Appendicitis?

Appendicitis (inflammation of the appendix) is found to be associated with 835 drugs and 895 conditions by eHealthMe. Check the latest studies of Appendicitis.

On Jul, 20, 2026

5,064 people reported to have side effects when taking Teriflunomide.
Among them, 12 people (0.24%) have Appendicitis.

Among these 12 people:

What is the gender of people who have Appendicitis when taking Teriflunomide? *

female: 80 %
male: 20 %

What is the age of people who have Appendicitis when taking Teriflunomide? *

What are other drugs people take besides Teriflunomide? *

What are other side effects people have besides Appendicitis? *

Wound Infection: 2 people, 16.67%
Urinary Tract Infection: 2 people, 16.67%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 2 people, 16.67%
Arthritis Infective (purulent invasion of a joint by an infectious agent which produces arthritis): 2 people, 16.67%
Bacteraemia (presence of bacteria in the blood): 2 people, 16.67%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 2 people, 16.67%
Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi): 2 people, 16.67%
Cellulitis (infection under the skin): 2 people, 16.67%
Clostridium Difficile Colitis (inflammation of colon by clostridium difficile bacteria infection): 2 people, 16.67%
Embolism (obstruction of an artery, typically by a clot of blood or an air bubble): 2 people, 16.67%

What are the existing conditions these people have? *

Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 7 people, 58.33%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 41.67%
Pain: 1 person, 8.33%
Insomnia (sleeplessness): 1 person, 8.33%
Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 1 person, 8.33%
Birth Control: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Teriflunomide and have Appendicitis?

- Check whether Appendicitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Teriflunomide:

Teriflunomide (5,067 reports)

Appendicitis treatments and more:

Appendicitis (11,953 reports)

Browse all side effects of Teriflunomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Appendicitis:

Appendicitis (835 drugs)

Browse all the conditions that are associated with Appendicitis:

Appendicitis (895 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on teriflunomide (the active ingredients of Teriflunomide) and Teriflunomide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.